PExA AB

PEXA B

SE0007412374

Advanced Medical Equipment & Technology

End-of-day quote SPOTLIGHT STOCK MARKET AB Other stock markets 2026-08-06			5-day change	1st Jan Change
0.4200 ^SEK	+2.44%		-14.11%	+92.66%

07-28	Pexa's rights issue was oversubscribed	FW
07-13	Pexa - Interview with CEO Tomas Gustafsson	FW

Pexa - Q3 Presentation 2025

Published on 11/07/2025 at 06:01 am EST

Finwire - Translated by Marketscreener - See original

Add MarketScreener to your sources

PEXA AB

+2.44%

PEXA GROUP LIMITED

+2.42%

Medical technology company Pexa presented its report with CEO Tomas Gustafsson.

Link to the broadcast: https://www.youtube.com/watch?v=kYxU_moIi1A

Add MarketScreener to your sources

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Off-Hours Price	Change	5-day change	Capi.
	PEXA AB	0.4200SEK	+2.44%	-14.11%	5.48M
	PEXA GROUP LIMITED	7.815AUD	+2.42%	+5.32%	944M

Latest news about PExA AB

07-28	Pexa's rights issue was oversubscribed	FW
07-13	Pexa - Interview with CEO Tomas Gustafsson	FW
07-10	Pexa raises SEK10m in a directed share issue, Anders Hallberg becomes a major shareholder	FW
07-01	Pexa raises nearly 10 million kronor in fully guaranteed rights issue	FW
06-23	Pexa signs a SEK 7.5m contract with a global pharmaceutical company	FW
06-10	Pexa secures order from the US	FW
06-02	Doctoral thesis presents findings from studies using Pexa technology	FW
05-22	PExA AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-22	Pexa reports revenue growth in Q1 as bottom line improves	FW
05-13	Pexa joins Dutch research project for lung diseases as industrial partner	FW
05-06	PExA AB Auditor Raises 'Going Concern' Doubt	CI
05-04	Pexa secures order from German BAuA	FW
04-20	Additional funding for Örebro University strengthens Pexa's role in research environment	FW
03-05	Pexa Secures Norwegian Order for Research Instrument in Occupational Health Study	FW
03-04	Pexa Aims to Become a Tool for Early Detection of Lung Cancer - CEO	FW

PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

08-27 Earnings release - Q2 2026

More about the company